Pharmaceutical Industry Information Portal

HomeTagsNovavax

All posts by tag

Novavax

Novavax’s COVID vaccine is struggling to be rolled out in the EU

Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union's main countries in the early rollout,...

Novavax starts shipping its COVID vaccine to EU states

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the first doses of Nuvaxovid™ COVID-19 Vaccine...

Nuvaxovid is the first protein-based COVID-19 vaccine authorized in UK

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products...

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in...

EC approves contract for a potential COVID-19 vaccine with Novavax

Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses.

Novavax Covid-19 Vaccine demonstrates 90,4% Effective in Late-stage Trial

Biotech company Novavax said that its COVID-19 vaccine is 90.4% effective in a late-stage trial of nearly 30,000 people in the U.S. and Mexico
spot_img

Expert Articles

spot_img